Shire Pharmaceuticals is trying to make the case for Intuniv. Alcobra's Metadoxine's Phase II data was of interest, it remains to be seen if it will hold up in Phase III. AstraZeneca, Chelsea Therapeutics, Cortex Pharmaceuticals, Euthymics Bioscience, Mnemosyne, Otsuka, Prexa Pharmaceuticals, Supernus, Theravance, and Targacept

The youngest children in the classroom are significantly more likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) — and prescribed medication — than their peers in the same grade.

DENVER, Feb. 17, 2012 /PRNewswire/ -- Memory lapses and changes in mental functions occur naturally as we get older.

Researchers, funded by the U.S. Food and Drug Administration and the Agency for Health Research Quality, recently studied the cardiovascular risk of ADHD medications in adults.

OAKLAND, Calif., Dec.